Mylan-Biocon’s breast cancer biosimilar gets ANVISA nod
Biocon said currently biosimilar trastuzumab will be manufactured by it and supplied to Libbs for commercialisation in Brazil
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.